Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
48.74
-0.38 (-0.77%)
At close: Feb 11, 2026, 4:00 PM EST
48.86
+0.12 (0.25%)
After-hours: Feb 11, 2026, 7:59 PM EST
Novo Nordisk (NVO) Operating Income by Segment
History
| Date | Diabetes and Obesity Care | Rare Disease |
|---|---|---|
| Sep 30, 2025 | 20.80B | 192.30M |
| Jun 30, 2025 | 22.27B | 333.01M |
| Mar 31, 2025 | 21.33B | 84.84M |
| Dec 31, 2024 | 20.21B | 98.13M |
| Sep 30, 2024 | 18.63B | 104.62M |
| Jun 30, 2024 | 17.56B | 79.77M |
| Mar 31, 2024 | 16.88B | 432.88M |
| Dec 31, 2023 | 15.77B | 467.07M |
| Sep 30, 2023 | 14.34B | 367.04M |
| Jun 30, 2023 | 12.98B | 657.32M |
| Mar 31, 2023 | 11.90B | 868.93M |
| Dec 31, 2022 | 10.67B | 1.17B |
| Sep 30, 2022 | 9.86B | 1.44B |
| Jun 30, 2022 | 9.05B | 1.46B |
| Mar 31, 2022 | 8.46B | 1.48B |
| Dec 31, 2021 | 7.84B | 1.44B |
| Sep 30, 2021 | 7.40B | 1.49B |
| Jun 30, 2021 | 6.88B | 1.63B |
| Mar 31, 2021 | 6.77B | 1.59B |
| Dec 31, 2020 | 6.92B | 1.64B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.